Pliant Therapeutics Announces Advancement of Integrin Target in Fibrosis Under Strategic…
Integrin target selected for development under 2019 collaboration following successful validation by PliantPliant to receive $4 million milestone payment and reimbursement in support of initiation of research and development activities…